Literature DB >> 25366628

Endovascular treatment of vasospasm related to acute subarachnoid hemorrhage from ruptured aneurysms.

Dmitry V Scheglov1, Mykola E Polischuk, Viktor I Scheglov, Maryna Y Mamonova, Lee H Monsein.   

Abstract

In the first 2 weeks after subarachnoid hemorrhage caused by a ruptured aneurysm, 30-35 % of surviving patients treated with conservative nonoperative therapy experience rebleeding. This is fatal in 60-90 % of cases and leads to significant disability in 17-20 % of cases. A major factor for this poor outcome is thought to be the vasospasm that occurs in up to 38.7 % by the third day, 46.3 % by the ninth day, and eventually in up to 70 % of patients. Endovascular treatment of aneurysms associated with acute subarachnoid hemorrhage has the potential to decrease the occurrence of rebleeding and therefore decrease the high mortality and morbidity associated with this disease. Treatment of vasospasm, if it does occur, has the potential to further improve patient outcomes. We describe the outcomes of 174 of our patients with acute subarachnoid hemorrhage caused by a ruptured aneurysm who were treated with endovascular techniques. Overall, the majority of our patients experienced a good or excellent outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25366628     DOI: 10.1007/978-3-319-04981-6_38

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  2 in total

1.  Perioperative Management of Subarachnoid Hemorrhage in a Patient with Alagille Syndrome and Unrepaired Tetralogy of Fallot: Case Report.

Authors:  Juan Fiorda-Diaz; Muhammad Shabsigh; Galina Dimitrova; Suren Soghomonyan; Gurneet Sandhu
Journal:  Front Surg       Date:  2017-12-04

Review 2.  Acute care for the three leading causes of mortality in lower-middle-income countries: A systematic review.

Authors:  Cassidy M Dahn; Olindi Wijesekera; Grace E Garcia; Konrad Karasek; Gabrielle A Jacquet
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.